Evaxion Appoints New Chief Executive Officer Evaxion A/S (NASDAQ: EVAX), a clinical-stage TechBio company, has appointed Dr. Helen Tayton-Martin as its new Chief Executive Officer (CEO).
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology The global oncology market is rapidly shifting …
Intersectional Disparities in Digital Health and Mental Health Service Use Among US Youth During the COVID-19 Pandemic A cross-sectional a…
Throwback Series: Managing Bilateral Diabetic Macular Edema David Eichenbaum, MD, FASRS, recalls a case from early in his career where he …
Insurance: Protecting Against AI’s Dark Side Executives face AI-driven cyber threats. Insurers, reinsurers, and corporates are navigating …
Scientists Use AI to Learn the Language of Biomolecules Scientists at the University of Glasgow have developed a new machine learning mode…
Assessing the Success of Salt Lake City's 'No Kings' Protest Organizers of Salt Lake City's second "No Kings" protest have reflected on th…
Horoscopes for October 27, 2025 Notable celebrities born on this day include Kelly Osbourne, Patrick Fugit, Peter Firth, and John Cleese.
Mars May Have Microbes Frozen In Its Icy Surfaces In the lab, researchers recreated the conditions on Mars. If there is life on Mar…
EGAT Awards ANDRITZ Contract to Modernize Srinagarind Hydropower Plant The Electricity Generating Authority of Thailand (EGAT) has chosen …
Netflix's "Wayward" Leaves Viewers Lost Netflix's latest psychological thriller, "Wayward", was released last month. The series is set in …